@article {1760,
	title = {Acquired haemophilia due to factor VIII inhibitors in ovarian hyperstimulation syndrome: case report.},
	volume = {18},
	year = {2003},
	note = {Record Owner: From MEDLINE, a database of the U.S. National Library of Medicine.; Status: MEDLINE; Comments: Comment in: Hum Reprod. 2007 Aug;22(8):2348-9; PMID: 17513318; Publishing Model: Journal available in: Print Citation processed from: Print; NLM Journal Code: hrp, 8701199; CAS Registry/EC Number/Name of Substance: 0 (Blood Coagulation Factors). 37224-63-8 (prothrombin complex concentrates). 78690-39-8 (Feiba). 9001-27-8 (Factor VIII).; Entry Date: 20031030},
	month = {Mar},
	pages = {6},
	address = {England},
	abstract = {A 31-year-old nulligravida woman developed an acquired factor VIII inhibitor associated with severe ovarian hyperstimulation syndrome (OHSS). She developed haematouria, ecchymosis, and intramuscular bleeding following the severe OHSS. Laboratory examinations showed a markedly prolonged activated partial thromboplastin time and a low level of factor VIII activity. Treatment with prothrombin complex concentrate and factor VIII inhibitor bypassing agent was successful in reducing the inhibitor so that she delivered a healthy baby via spontaneous vaginal delivery. Acquired haemophilia is a life-threatening disorder. This is the first case report of acquired haemophilia in OHSS.},
	keywords = {Adult, Blood Coagulation Factors / tu [Therapeutic Use], Delivery, Obstetric, Factor VIII / ai [Antagonists \& Inhibitors], Female, Hemophilia A / dt [Drug Therapy], Hemophilia A / et [Etiology], Humans, IM, Infant, Newborn, Male, Ovarian Hyperstimulation Syndrome / co [Complications], Ovarian Hyperstimulation Syndrome / me [Metabolism], Pregnancy},
	issn = {0268-1161},
	url = {http://ovidsp.ovid.com/ovidweb.cgi?T=JS\&CSC=Y\&NEWS=N\&PAGE=fulltext\&D=med4\&AN=12615815},
	author = {Nakauchi-Tanaka,T. and Sohda,S. and Someya,K. and Kono,K. and Hamada,H. and Yoshikawa,H.}
}
